SAN DIEGO, Aug. 17, 2020 /PRNewswire-PRWeb/ -- Inc. magazine today announced that, the healthcare industry's leading marketplace for life science research, ranked no. 909 on its Inc. 5000 list, a ranking of the nation's fastest-growing private companies. This is the fourth year in a row that has made the list, which is a snapshot of the most successful independent small businesses in the US.

"Revenue growth means little if we're not making people's lives better," stated Kevin Lustig, PhD,'s CEO and Founder. "We are doing everything in our power to help scientists in the biopharma industry continue their research virtually as they search for new cures and vaccines for COVID-19 and other diseases. Working together without regard to race, gender or political affiliation, we can eliminate COVID-19 and every human disease." has spent the last thirteen years building an award-winning marketplace that helps scientists focus more on science and less on paperwork. Its Biotech as a Service(TM) platform helps researchers test more ideas in less time and at lower cost. It digitizes a company's entire research operations, automatically tracking purchases, managing contracts, handling payments and generating business intelligence reports. helps biotech companies do groundbreaking R&D faster than ever before.

"The companies on this year's Inc. 5000 come from nearly every realm of business," says Inc. editor-in-chief Scott Omelianuk. "From health and software to media and hospitality, the 2020 list proves that no matter the sector, incredible growth is based on the foundations of tenacity and opportunism."

Complete results of the Inc. 5000, including company profiles and industry rankings, can be found at

About is the pharmaceutical industry's leading AI-powered marketplace for outsourced R&D. The marketplace simplifies R&D sourcing, saving time and money, reducing risk and providing access to the latest innovative tools and technologies. operates enterprise R&D marketplaces for 24 of the world's top 30 pharmaceutical companies, the Biotechnology Innovation Organization (BIO) and the US National Institutes of Health (NIH). Since its founding in 2007, has raised $39 million from 5AM Ventures, Transformation Capital and Bootstrap Ventures among others.

Visit to learn more.

Join on social media: LinkedIn, Twitter, YouTube, Facebook and Instagram

Media Contact:
Sean Preci
Director of Communications
+1 858 455-1300 ext. 401


Copyright 2020 PR Newswire